0001415889-17-001503.txt : 20170918
0001415889-17-001503.hdr.sgml : 20170918
20170918172029
ACCESSION NUMBER: 0001415889-17-001503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170915
FILED AS OF DATE: 20170918
DATE AS OF CHANGE: 20170918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIER PAUL V
CENTRAL INDEX KEY: 0001182615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37861
FILM NUMBER: 171090506
MAIL ADDRESS:
STREET 1: 3595 JOHN HOPKINS COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MABVAX THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001109196
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930987903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11535 SORRENTO VALLEY ROAD
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582599405
MAIL ADDRESS:
STREET 1: 11535 SORRENTO VALLEY ROAD
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TELIK INC
DATE OF NAME CHANGE: 20000313
4
1
form4-09182017_050919.xml
X0306
4
2017-09-15
0001109196
MABVAX THERAPEUTICS HOLDINGS, INC.
MBVX
0001182615
MAIER PAUL V
C/O MABVAX THERAPEUTICS HOLDINGS, INC.
11535 SORRENTO VALLEY RD., SUITE 400
SAN DIEGO
CA
92121
true
false
false
false
Restricted Stock Unit
2017-09-15
4
A
0
24210
A
Common Stock
24210
24210
D
Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts.
/s/ Paul V. Maier
2017-09-18